Related Experiment Videos

Splenectomy in Nigerian children with sickle cell anaemia

B A Okoro1, W N Kaine, T C Okeahialam

  • 1Department of Paediatrics, University of Nigeria Teaching Hospital, Enugu.

Tropical and Geographical Medicine
|April 1, 1989
PubMed

Insights

Splenectomy improved health in Nigerian children with sickle cell anaemia and hypersplenism. However, it did not eliminate pain crises, limiting its use for most patients.

Area of Science:

  • Pediatrics
  • Hematology
  • Surgical Oncology

Background:

  • Sickle cell anaemia is a prevalent genetic blood disorder in Nigeria.
  • Hypersplenism can complicate sickle cell anaemia, leading to intractable symptoms.
  • Splenectomy is a potential treatment for hypersplenism.

Observation:

  • This study reviewed 4359 children with sickle cell anaemia treated between 1979-1986.
  • Four children with hypersplenism underwent splenectomy for intractable complaints.
  • Outcomes were monitored for improvements in haematological indices and general wellbeing.

Findings:

  • Splenectomy led to improved haematological parameters and overall wellbeing in the treated children.
  • However, splenectomy did not eradicate abdominal or bone pain crises associated with sickle cell anaemia.
  • The benefits of splenectomy were observed in carefully selected cases of hypersplenism.

Implications:

  • Splenectomy can be a beneficial therapeutic option for select pediatric patients with sickle cell anaemia and hypersplenism.
  • It is not a primary treatment modality for the majority of children suffering from sickle cell anaemia in Nigeria.
  • Further research may explore alternative or adjunctive therapies to manage pain crises effectively in these patients.

Related Concept Videos